MediSapiens
Helsinki · Founded 2009
About MediSapiens
MediSapiens is the world’s first software company for personalized cancer medicine in oncology clinics and new drug development. Company’s bioinformatics science and peer-reviewed data is based on the research since 2005 by VTT, Technical Research Centre of Finland and its collaborators. Company's online genomics data enables scientists to understand the role of human genes in health and disease ’ helping oncologists in choosing optimal treatments and biopharmaceutical companies in developing next generation personalized medicines.
Company Facts
- Founded: 2009
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $1.0M
- Last round: Series Unknown (Mar 2011)
- Website: http://www.medisapiens.com/
- Phone: 358 5036 31848
Industries & Categories
Apps, Biopharma, Pharmaceutical, Software
Social Profiles
Canonical: https://fsome.com/organization/medisapiens-3020960 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.